Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.5702
-0.0070-1.21%
Volume:10.86K
Turnover:6.31K
Market Cap:3.32M
PE:-0.22
High:0.6000
Open:0.5800
Low:0.5701
Close:0.5772
Loading ...

Company Profile

Company Name:
NovaBay Pharmaceuticals
Exchange:
AMEX
Establishment Date:
2000
Employees:
14
Office Location:
2000 Powell Street,Suite 1150, eleventh floor,EmeryVille,California,United States
Zip Code:
94608
Fax:
510 474 1577
Introduction:
NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Directors

Name
Position
Justin M. Hall
Director,Chief Executive Officer, General Counsel and Chief Compliance Officer
Julie Garlikov
Independent Director
Paul E. Freiman
Chair,Independent Director
Swan Sit
Independent Director
Yenyou Zheng
Independent Director
Mijia Wu
Director
Sean Zheng
Director

Shareholders

Name
Position
Justin M. Hall
Director,Chief Executive Officer, General Counsel and Chief Compliance Officer
Tommy Law
Interim Chief Financial Officer and Treasurer
Audrey Kunin
Chief Product Officer
Jeff Kunin
President, DERMAdoctor